Molecular basis for heterogeneity of the human p53 protein
- PMID: 3025664
- PMCID: PMC367250
- DOI: 10.1128/mcb.6.12.4650-4656.1986
Molecular basis for heterogeneity of the human p53 protein
Abstract
The human p53 tumor antigen comprises several physically distinct proteins. Two p53 proteins, separable by polyacrylamide gel electrophoresis, are expressed by the human transformed cell line SV-80. The individual cDNAs which code for these proteins were isolated and constructed into the SP6 transcription vector. The proteins encoded by these clones were identified by in vitro transcription with the SP6 vector and translation in a cell-free system. p53-H-1 and p53-H-19 cDNA clones code for the faster- and slower-migrating p53 protein species, respectively, of SV-80. The in vitro-expressed proteins of p53-H-1 and p53-H-19 had the same antigenic determinants and were structurally indistinguishable from their in vivo counterparts. By expressing defined restricted cDNA fragments in vitro, the region of heterogeneity between the respective cDNAs was located at the 5' end of the cDNAs. Exchanging the 5' fragments of interest and expressing the chimeric clones in vitro confirmed that the DNA heterogeneity was responsible for the difference in the electrophoretic mobility of these proteins. The sequences of the two cDNAs revealed a single base pair difference (G versus C) in the coding region of the clones. This sequence difference resulted in an arginine being coded for in clone p53-H-1 and a proline being coded for at the equivalent position in clone p53-H-19. This variation accounted for the change in the electrophoretic mobility of the individual p53 protein species.
Similar articles
-
Immunologically distinct p53 molecules generated by alternative splicing.Mol Cell Biol. 1986 Sep;6(9):3232-9. doi: 10.1128/mcb.6.9.3232-3239.1986. Mol Cell Biol. 1986. PMID: 3023970 Free PMC article.
-
In vitro expression of human p53 cDNA clones and characterization of the cloned human p53 gene.Mol Cell Biol. 1985 Aug;5(8):1887-93. doi: 10.1128/mcb.5.8.1887-1893.1985. Mol Cell Biol. 1985. PMID: 3018534 Free PMC article.
-
Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.Mol Cell Biol. 1985 Jul;5(7):1601-10. doi: 10.1128/mcb.5.7.1601-1610.1985. Mol Cell Biol. 1985. PMID: 3894933 Free PMC article.
-
A variation in the structure of the protein-coding region of the human p53 gene.Gene. 1988 Oct 30;70(2):245-52. doi: 10.1016/0378-1119(88)90196-5. Gene. 1988. PMID: 2905688
-
The p53 cellular tumor antigen: gene structure, expression and protein properties.Biochim Biophys Acta. 1985 Nov 12;823(1):67-78. doi: 10.1016/0304-419x(85)90015-0. Biochim Biophys Acta. 1985. PMID: 3902087 Review. No abstract available.
Cited by
-
Genetic Modifiers of the p53 Pathway.Cold Spring Harb Perspect Med. 2016 Apr 1;6(4):a026302. doi: 10.1101/cshperspect.a026302. Cold Spring Harb Perspect Med. 2016. PMID: 27037420 Free PMC article. Review.
-
Characterization of mutations in Gaucher patients by cDNA cloning.Am J Hum Genet. 1989 Mar;44(3):365-77. Am J Hum Genet. 1989. PMID: 2464926 Free PMC article.
-
Lack of correlation between p53 codon 72 polymorphism and anal cancer risk.World J Gastroenterol. 2009 Sep 28;15(36):4566-70. doi: 10.3748/wjg.15.4566. World J Gastroenterol. 2009. PMID: 19777616 Free PMC article.
-
Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.Mol Biol Rep. 2012 Apr;39(4):4683-90. doi: 10.1007/s11033-011-1260-x. Epub 2011 Sep 28. Mol Biol Rep. 2012. PMID: 21952824
-
The TP53 tumor suppressor gene: From molecular biology to clinical investigations.J Intern Med. 2025 Aug;298(2):78-96. doi: 10.1111/joim.20106. Epub 2025 Jun 16. J Intern Med. 2025. PMID: 40524430 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous